Feb 16, 2021 4:45pm EST

Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

Feb 10, 2021 11:00pm EST

Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

Feb 01, 2021 5:16pm EST

Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market

Jan 28, 2021 4:01pm EST

Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market

Jan 07, 2021 4:05pm EST

Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright

Nov 12, 2020 4:25pm EST

Cancer Genetics Reports Third Quarter 2020 Financial Results

Nov 02, 2020 4:00pm EST

Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares

Oct 28, 2020 9:55pm EDT

Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million

Oct 28, 2020 5:54pm EDT

Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering

Sep 10, 2020 8:00am EDT

Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference